NEW YORK, NY (October 18, 2016) – Schrodinger, Inc. and China's Tsinghua University's School of Pharmaceutical Sciences have reached an agreement to establish a Center of Excellence (COE) in Structure-Based Drug Discovery at Tsinghua University. Under the terms of the agreement, Schrodinger will provide its computational chemistry software to the COE, and work with the faculty at Tsinghua University to create a curriculum for researchers at the University and throughout China on using Schrodinger's software solutions in drug discovery.


 

“We're honored to be chosen as the technology platform by Tsinghua University, a world renowned and distinguished institution,” said Schrodinger's president, Dr. Ramy Farid. “Our platform has demonstrated successes in drug discovery programs, and we are excited to share our technology with our partners and researchers in China.”
 

The COE will focus on developing the knowledge and expertise of Tsinghua researchers by providing training in the underlying theories of computational chemistry and the application of Schrodinger's simulation tools in the drug discovery process. Additionally, under the terms of the agreement, Schrodinger and Tsinghua University may enter into research collaborations on projects of mutual interest.
 
“We are very happy to work with Schrodinger, the clear science and technology leader in this field,” said Dr. Sheng Ding of Tsinghua University. “We are very proud of the Center of Excellence – it supports the educational mission of Tsinghua University and together with our renowned structural biology capability will provide Chinese scientists with the tools to develop innovative medicines and therapeutic approaches to improve human health.”
 
 
#  #  #
 
About Schrodinger
Schrodinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for life sciences and materials research.  Schrodinger also establishes deep partnerships and collaborations with companies in such fields as biotechnology, pharmaceuticals, chemicals, and electronics.  Through significant long-term investments in basic research, Schrodinger has made scientific breakthroughs across many areas of drug discovery and materials science.  Hundreds of peer-reviewed scientific publications by Schrodinger scientists are frequently among the most heavily cited in their fields.  Founded in 1990, Schrodinger has nearly 300 employees and operations in the United States, Europe, Japan, and India, as well as business partners in China and Korea.